Dual Energy CT Urography With Reduced Iodinated Contrast
NCT ID: NCT02283307
Last Updated: 2018-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2014-09-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thoracoabdominal Arortic CTA Study
NCT02291718
Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study
NCT02669784
Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)
NCT04328181
Chest CT Using Low-concentration Iodine Contrast Media
NCT05967117
Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol
NCT00611780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Enhancement of the aorta, renal arteries, and renal veins
* Enhancement of the renal cortex
* Enhancement of the renal pelvis, ureters, and bladder
* Subjective evaluation of image quality
* Objective evaluation of image quality
In addition, the investigators hypothesize that DECT virtual non-contrast images using material suppression from the same low iodine CT exam results in equivalent diagnostic information compared to SECT true non-contrast images obtained in the same patient during the same exam. If the true non-contrast images could be replaced by the virtual non-contrast images without loss of information, there is potential for DECT to both significantly lower radiation dose as well as significantly decreasing iodine dose.
The investigators designed this research protocol to prospectively test these hypotheses in a population scanned with a 50% reduced iodine DECT urography protocol compared to a control population scanned with a standard iodine dose clinical SECT urography protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reduced contrast DECT scan
Reduced Contrast Dual Energy CT
Reduced contrast DECT scan
Subjects will undergo a dual energy CT scan with reduced contrast
Standard contrast SECT scan
Subjects will undergo standard of care single energy CT scan with a standard dose of contrast. (control)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reduced contrast DECT scan
Subjects will undergo a dual energy CT scan with reduced contrast
Standard contrast SECT scan
Subjects will undergo standard of care single energy CT scan with a standard dose of contrast. (control)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient scheduled to have a CT urography at the site
Exclusion Criteria
* Pregnancy (which is very unlikely for those over 50)
* Body mass index (BMI) over 35 kg/m2
* Inability to provide informed consent
* Inpatient
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Shuman
Professor and Vice Chair of Radiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
47637
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.